Riverview Trust Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-486
| Closed | -$20.2K | – | 745 |
|
|
2024
Q4 | $20.2K | Buy |
+486
| New | +$20.2K | 0.02% | 460 |
|
|
2024
Q3 | – | Sell |
-173
| Closed | -$20.5K | – | 843 |
|
|
2024
Q2 | $20.5K | Hold |
173
| – | – | 0.02% | 418 |
|
|
2024
Q1 | $18.4K | Buy |
+173
| New | +$18.4K | 0.01% | 515 |
|
|
2023
Q4 | – | Sell |
-272
| Closed | -$28.1K | – | 437 |
|
|
2023
Q3 | $28.1K | Buy |
272
+65
| +31% | +$6.71K | 0.02% | 315 |
|
|
2023
Q2 | $25.2K | Buy |
207
+46
| +29% | +$5.59K | 0.02% | 304 |
|
|
2023
Q1 | $24.7K | Buy |
161
+11
| +7% | +$1.69K | 0.02% | 302 |
|
|
2022
Q4 | $27K | Sell |
150
-89
| -37% | -$16K | 0.03% | 296 |
|
|
2022
Q3 | $28K | Buy |
239
+40
| +20% | +$4.69K | 0.03% | 296 |
|
|
2022
Q2 | $28K | Sell |
199
-36
| -15% | -$5.07K | 0.02% | 303 |
|
|
2022
Q1 | $40K | Buy |
+235
| New | +$40K | 0.03% | 248 |
|